A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia

• Egile Nagusiak: Lickliter JD (Egilea), Gan HK (Egilea), Voskoboynik M (Egilea), Arulananda S (Egilea), Gao B (Egilea), Nagrial A (Egilea), Grimison P (Egilea), Harrison M (Egilea), Zou J (Egilea), Zhang L (Egilea), Luo S (Egilea), Lahn M (Egilea), Kallender H (Egilea), Mannucci A (Egilea), Somma C (Egilea), Woods K (Egilea), Behren A (Egilea), Fernandez-Penas P (Egilea), Millward M (Egilea), Meniawy T (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2020-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Jason D Lickliter, 1 Hui K Gan, 2–4 Mark Voskoboynik, 1, 5, 6 Surein Arulananda, 2–4 Bo Gao, 7 Adnan Nagrial, 7 Peter Grimison, 8 Michelle Harrison, 8 Jianjun Zou, 9 Lianshan Zhang, 9 Stacey Luo, 9 Michael Lahn, 10 Howard Kallender, 11 Andrea Mannucci, 10 Catello Somma, 10 Kather...